Urinary Bladder Neoplasms: all 1,649 studies

Page 7 of 17. Open to participants first (427), then studies with results posted, then the rest; newest registration first within each.

• Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had ChemotherapyTerminatedNCT01339000Phase 2Results posted
• Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial CarcinomaTerminatedNCT01331824Phase 2Results posted
• A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial CancerCompletedNCT01326871Phase 1/2Results posted
• Cancer in Patients With Gabapentin (GPRD)CompletedNCT01236053Results posted
• S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder CancerCompletedNCT01224665Not applicableResults posted
• First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial CarcinomaTerminatedNCT01215136Phase 2Results posted
• Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder CancerTerminatedNCT01200992Phase 3Results posted
• Comparison Study of Narrow Band Imaging Versus White Light Resection in Patients With Bladder Tumors/CancerCompletedNCT01180478Not applicableResults posted
• Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURBCompletedNCT01166230Results posted
• Open Vs Robotic-Assisted Radical Cystectomy: A Randomized TrialCompletedNCT01157676Not applicableResults posted
• Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder CancerTerminatedNCT01126749Phase 1/2Results posted
• Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder CancerTerminatedNCT01118351Phase 2Results posted
• Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial CancerCompletedNCT01108055Phase 2Results posted
• Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing SurgeryTerminatedNCT01108003Not applicableResults posted
• Dose Dense MVAC for Muscle Invasive Bladder CancerCompletedNCT01031420Phase 2Results posted
• Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial CancerTerminatedNCT00995488Phase 2Results posted
• Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder CancerCompletedNCT00981656Phase 2Results posted
• A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)CompletedNCT00978250Phase 2Results posted
• Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer PatientsTerminatedNCT00974818Phase 3Results posted
• Robotic-Assisted Laparoscopic Extended Pelvic Lymph Node Dissection for Transitional Cell Carcinoma of the BladderCompletedNCT00963859Phase 2Results posted
• Acceptability of Less Harmful Alternatives to CigarettesCompletedNCT00957424Not applicableResults posted
• Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCCTerminatedNCT00859339Phase 2Results posted
• Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder CancerCompletedNCT00847015Phase 2Results posted
• Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial CarcinomaCompletedNCT00808639Phase 2Results posted
• Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device?TerminatedNCT00802633Not applicableResults posted
• Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop SmokingCompletedNCT00790569Not applicableResults posted
• Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by SurgeryCompletedNCT00777491Phase 2Results posted
• A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)CompletedNCT00753415Phase 1Results posted
• Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial CancerCompletedNCT00749892Phase 2Results posted
• Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder CancerCompletedNCT00734994Early Phase 1Results posted
• Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary BladderCompletedNCT00722553Phase 2Results posted
• Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy TreatmentCompletedNCT00710970Phase 2Results posted
• Neoadjuvant Dasatinib and Radical Cystectomy for Transitional Cell Carcinoma of the BladderCompletedNCT00706641Not applicableResults posted
• Health Education Counseling With or Without Bupropion in Helping African Americans Stop SmokingCompletedNCT00666978Phase 4Results posted
• Green Tea Extract in Treating Patients With Nonmetastatic Bladder CancerCompletedNCT00666562Phase 2Results posted
• A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder CancerCompletedNCT00661609Phase 2Results posted
• Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial CancerCompletedNCT00645593Phase 2Results posted
• Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder CancerCompletedNCT00634621Results posted
• Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612)CompletedNCT00598806Phase 3Results posted
• Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder CancerCompletedNCT00595088Phase 2Results posted
• Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain MetastasesCompletedNCT00587964Phase 2Results posted
• Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder CancerCompletedNCT00585689Phase 2Results posted
• Intravesicular Abraxane for Treatment-Refractory Bladder CancerCompletedNCT00583349Phase 1/2Results posted
• Bupropion in Helping Adults Stop SmokingCompletedNCT00534001Phase 2Results posted
• Sunitinib in Treating Patients With Locally Advanced Bladder CancerCompletedNCT00526656Phase 2Results posted
• Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial CancerCompletedNCT00506155Phase 2Results posted
• Iressa and Taxotere Study in Patients With Metastatic Urothelial CancerTerminatedNCT00479089Phase 2Results posted
• Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney FunctionCompletedNCT00478361Phase 2Results posted
• Pazopanib in Treating Patients With Metastatic Urothelial CancerCompletedNCT00471536Phase 2Results posted
• Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In SituCompletedNCT00462488Phase 2Results posted
• Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder CarcinomaCompletedNCT00461851Phase 2Results posted
• Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611)CompletedNCT00461591Phase 3Results posted
• S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder CancerCompletedNCT00445601Phase 3Results posted
• A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse TreatmentCompletedNCT00421889Phase 1/2Results posted
• A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder CancerCompletedNCT00412971Phase 3Results posted
• VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the UrotheliumCompletedNCT00407485Phase 2Results posted
• Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the UrotheliumCompletedNCT00397488Phase 2Results posted
• Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder CancerCompletedNCT00380029Phase 2Results posted
• Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit SmokingCompletedNCT00365508Phase 4Results posted
• Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the UrotheliumTerminatedNCT00363883Phase 2Results posted
• Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder CancerCompletedNCT00318643Phase 1/2Results posted
• Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By SurgeryTerminatedNCT00268450Phase 2Results posted
• Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder CancerCompletedNCT00238420Phase 1/2Results posted
• Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell CancerCompletedNCT00234494Phase 2Results posted
• S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-GuerinCompletedNCT00234039Phase 2Results posted
• Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence CystoscopyCompletedNCT00233402Phase 3Results posted
• Instillation of Gemcitabine in Patients With Superficial Bladder CancerTerminatedNCT00191477Phase 3Results posted
• A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle ContrastTerminatedNCT00147238Not applicableResults posted
• Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder CancerCompletedNCT00118040Phase 2Results posted
• Sorafenib in Treating Patients With Regional or Metastatic Cancer of the UrotheliumTerminatedNCT00112905Phase 2Results posted
• Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary TractCompletedNCT00112671Phase 2Results posted
• Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder CancerTerminatedNCT00089128Phase 2Results posted
• Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder CancerCompletedNCT00055601Phase 2Results posted
• S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the UrotheliumCompletedNCT00045630Phase 2Results posted
• S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary TractTerminatedNCT00022633Phase 2Results posted
• 4B951, Combination Chemotherapy in Treating Patients With Bladder CancerTerminatedNCT00005047Phase 3Results posted
• Bladder Preservation or Cystectomy for MIBCActive, not recruitingNCT07821177Early Phase 1
• Age and Bladder Cancer Outcomes After BCG Treatment: A Multicenter StudyCompletedNCT07798479
• Microfluidic Urinary Exosome-Based Diagnostic Model for Bladder CancerActive, not recruitingNCT07735858
• Predictive Value of E-cadherin, β-catenin and SOX4 in Recurrence and/or Progression of Non-muscle Invasive Urinary Bladder Transitional Cell Carcinoma. A Retrospective StudyCompletedNCT07657299
• STENT X: a Randomized Trial to Assess Stent-free Radical CystectomyWithdrawnNCT07655284Phase 3
• Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)CompletedNCT07568444Phase 2
• Holmium Laser En-Bloc Resection Versus Conventional Transurethral Resection of Bladder Tumors for Treatment of Non-muscle- Invasive Bladder CancerCompletedNCT07534631Not applicable
• BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder CancerActive, not recruitingNCT07511517
• Closed-System Bladder Irrigation to Reduce Urinary Tract Infections After Endoscopic Urologic Surgery (IRIS Trial)CompletedNCT07510685Not applicable
• COMPARISON OF OBTURATOR NERVE BLOCK TECHNIQUES IN TURBTCompletedNCT07481123Not applicable
• Magnesium vs. Dexmedetomidine in TURBT Under Spinal AnesthesiaCompletedNCT07445451Not applicable
• A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder CancerWithdrawnNCT07414992Phase 2
• CRUCIAL-R Study : Cruciferous Vegetables Dietary Regimen in NMIBCActive, not recruitingNCT07391137Not applicable
• Comparison of Pathological Outcome and Recurrence Rate Between En Bloc and Conventional Transurethral Resection of Bladder TumorCompletedNCT07347132Not applicable
• A Study of Adjuvant NDV-01 (Sustained-release Gemcitabine-docetaxel) for the Treatment of Intermediate Risk NMIBC Following TURBTWithdrawnNCT07313891Phase 3
• DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised TherapyActive, not recruitingNCT07265414
• Histopathological Findings in En-Bloc vs Conventional Transurethral Resection of Bladder Tumors.CompletedNCT07259798Not applicable
• Development of Multiphasic CT-based Delta-Radiomics Model for Predicting Postoperative Recurrence Risk in Bladder CancerCompletedNCT07251946
• The Impact of Intelligent Nursing Based on Health Cloud Platform on Active Health Management of Urostomy PatientsCompletedNCT07201441Not applicable
• Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder CancerActive, not recruitingNCT07180212Not applicable
• Use of Wearables Following Cystectomy- Part IIActive, not recruitingNCT07148765Not applicable
• Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersActive, not recruitingNCT07118176Phase 1
• ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid TumorsCompletedNCT06973161
• Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.CompletedNCT06955910

← Urinary Bladder Neoplasms overview